(Q37950144)

English

Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: a Gynecologic Oncology Group study

scientific article published on 26 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: a Gynecologic Oncology Group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1 reference

based on heuristic

inferred from title

gynecologic oncology

1 reference

based on heuristic

inferred from title

author name string

Bunja Rungruang

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Austin Miller

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Scott D Richard

3

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Chad A Hamilton

4

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Noah Rodriguez

5

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Michael A Bookman

6

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

G Larry Maxwell

7

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Thomas C Krivak

8

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Neil S Horowitz

9

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

language of work or name

0 references

publication date

26 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

124

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

53-58

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Aortic lymph node metastases in early ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Survival of ovarian carcinoma with or without lymph node metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Lymphadenectomy in stage I ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Factors influencing survival in carcinoma of the ovary. Study from a well-defined Swedish population

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Significance of lymph node sampling in epithelial carcinoma of the ovary.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Assessing the adequacy of surgical staging for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.024

7 January 2021

Identifiers

10.1016/J.YGYNO.2011.09.024

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37950144&oldid=2168238503"